These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8204207)

  • 1. Selective effect of alcohol on cellular immune responses of lymphocytes from AIDS patients.
    Nair MP; Kumar NM; Kronfol ZA; Saravolatz LA; Pottathil R; Greden JF; Schwartz SA
    Alcohol; 1994; 11(2):85-90. PubMed ID: 8204207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I.
    Nair MP; Schwartz SA
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of human immunodeficiency virus type 1 protein-induced inhibition of natural killer cell activity by alpha interferon and interleukin-2.
    Nair MP; Schwartz SA
    Clin Diagn Lab Immunol; 2000 Jan; 7(1):101-5. PubMed ID: 10618286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes.
    Nair MP; Pottathil R; Heimer EP; Schwartz SA
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6498-502. PubMed ID: 3045818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients.
    Rinaldo C; Huang XL; Piazza P; Armstrong J; Rappocciolo G; Pazin G; McMahon D; Gupta P; Fan Z; Zhang Z
    J Infect Dis; 1991 Oct; 164(4):638-45. PubMed ID: 1680135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina.
    Galvin TA; Muller J; Khan AS
    Vaccine; 2000 May; 18(23):2566-83. PubMed ID: 10775791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
    Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
    Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of cortisol and HIV-1 envelope peptide on the NK activities of normal lymphocytes.
    Nair MP; Schwartz SA
    Brain Behav Immun; 1995 Mar; 9(1):20-30. PubMed ID: 7620208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant proteins derived from immunodominant regions of the gag and env genes of HIV-1 and their potential for use in serologic diagnosis.
    Kovác J
    Acta Virol; 1991 Aug; 35(4):383-90. PubMed ID: 1686963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.
    Denner J; Norley S; Kurth R
    AIDS; 1994 Aug; 8(8):1063-72. PubMed ID: 7986401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte proliferative responses to HIV-1 envelope and core antigens by infected and uninfected adults and children.
    Borkowsky W; Krasinski K; Moore T; Papaevangelou V
    AIDS Res Hum Retroviruses; 1990 May; 6(5):673-8. PubMed ID: 2113821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
    Ahmad A; Ladha A; Cohen EA; Menezes J
    Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of IL-15 in challenging Acquired Immunodeficiency Syndrome.
    d'Ettorre G; Andreotti M; Ceccarelli G; Galluzzo CM; Mallano A; Massetti AP; Tierno F; Stella S; Amici R; Vella S; Mastroianni CM; Vullo V
    Cytokine; 2012 Jan; 57(1):54-60. PubMed ID: 22055728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection.
    Fehniger TA; Herbein G; Yu H; Para MI; Bernstein ZP; O'Brien WA; Caligiuri MA
    J Immunol; 1998 Dec; 161(11):6433-8. PubMed ID: 9834136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the recombinant chimera proteins, LacZ-Env and Gag-Env, for immunological studies on HIV-1 infection.
    Morimoto M; Saitoh A; Ueba N; Nakata A; Shinagawa H
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):971-8. PubMed ID: 7506555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant HIV structural proteins detect specific cellular immunity in vitro in infected individuals.
    Torseth JW; Berman PW; Merigan TC
    AIDS Res Hum Retroviruses; 1988 Feb; 4(1):23-30. PubMed ID: 2835070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo induction of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes and delayed-type hypersensitivity by a 23-amino acid peptide from the highly conserved region in major core protein p24.
    Nishino Y; Kameoka M; Okada Y; Zhong Q; Kimura T; Azuma I; Ikuta K
    Vaccine; 1994 May; 12(6):485-91. PubMed ID: 7913566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional integrity of T, B, and natural killer cells in homosexual subjects with prodromata and in patients with AIDS.
    Bekesi JG; Tsang P; Lew F; Roboz JP; Teirstein A; Selikoff IJ
    Ann N Y Acad Sci; 1984; 437():28-38. PubMed ID: 6335953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
    Gooneratne SL; Center RJ; Kent SJ; Parsons MS
    Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.